MapLight Therapeutics logo
MapLight Therapeutics
MPLT | NASDAQ
Chart Builder DCF Calculator
$6.90
-$0.35 (-4.83%)
At close: Nov 16, 2026, 4:00 PM ET
$7.03
+$0.13 (+1.88%)
After-hours: Nov 16, 2026, 4:40 PM ET

MapLight Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q1 2023
Mar 31, 2023
-60.19M -60.67M -79.55M -29.42M -29.85M -22.34M -21.23M -19.02M -18.4M -18.94M -11.98M
147K 162K 140K 136K 136K 166K 194K 187K 173K 147K 128K
– – – 125K – – 214K 354K – – –
8.46M 384K -1.72M -2.69M -5.18M -3.54M -366K -697K 218K -2.09M -502K
7.84M 9.06M 34.3M -240K 920K 167K -144K -712K 477K 940K 371K
– – – – – – – – – – –
7.33M 273K -1.72M -2.39M -5.18M -3.54M -523K -667K 218K -2.09M -502K
-44.87M -51.18M -46.83M -31.79M -33.97M -25.55M -21.49M -19.85M -17.53M -19.94M -11.98M
-22K -24K -376K -31K -66K – -106K -374K -288K -2K -77K
– – – – – – – – – – –
-19.77M – -266.18M -142.06M – – – -3.49M -121.53M – –
80.5M 67.03M 24M 6.5M 17.5M 37.5M 32.5M 12.5M – – –
– – – – – – – – – – –
60.7M 67.01M -242.55M -135.59M 17.43M 37.5M 32.39M 8.64M -121.82M -2K -77K
– – – – – – – – – – –
– – – – – – – – – – –
– – – – – – – – – – –
– -7.5M -3.89M -916K -159K -52K -17K -214K -1.96M – –
92K -6.85M 271.97M 198.06M -156K -47K 5K -207K -1.7M 119.96M 1K
15.93M 8.98M -17.42M 30.68M -16.69M 50.16M 10.91M -11.42M -179.81M 179.81M –
-44.89M -51.2M -47.21M -31.82M -34.03M -25.55M -21.59M -20.23M -17.82M -19.94M -12.06M
-44.89M -51.2M -47.21M -31.95M -34.03M -25.55M -21.81M -20.58M -17.82M -19.94M -12.06M
-22K -24K -140K -31K -66K – -106K -187K -173K -2K -77K
– – -236K – – – – -187K -115K – –
-44.89M -51.2M -46.97M -31.82M -34.03M -25.55M -21.59M -20.04M -17.71M -19.94M -12.06M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.